Market Access
The Global Impact of US Medicine Pricing: Who Really Pays?
Estimated read time 6 min
The US wants to bring down the cost of prescription medicines. But could its approach lead to higher prices elsewhere and change where pharmaceutical companies choose to launch new treatments?
Insights
The biggest barrier to AI adoption in healthcare isn’t regulation. It’s trust.
Estimated read time 7 min
Artificial intelligence has become one of the defining conversations in healthcare.
Insights
AI Copilot in the Doctor’s Office: myth, miracle or menace?
Estimated read time 10 min
AI copilots are increasingly being used in the healthcare setting - do they elevate care or risk clinical integrity?
Insights
Beyond Buzzwords: making ethical AI a reality for health brands
Estimated read time 10 min
Responsible AI sounds great, but real frameworks are scarce - learn how to build trust and avoid legal pitfalls.
Insights
What political debates can teach us about explaining science
Estimated read time 2 min
A century ago, political rallies were very different. Audiences would stand outside for hours, listening carefully as candidates explained their policies in detail.
Insights
How diagnostic innovation is improving access and early disease detection
Estimated read time 7 min
Early diagnosis is one of the most powerful strategies in modern healthcare. Yet too often, fear, discomfort and stigma prevent people from taking part in traditional screening programmes.
Evidence, Pricing, and Access Strategy
Most Favoured Nation Pricing in the US
Estimated read time 17 min
Payer Perspectives on Global Implications for Pharmaceutical Markets and Patient Access
Insights
The ‘Activation Gap’: turning AI daydreams into real patient outcomes
Estimated read time 9 min
Most teams want to use AI. Few succeed. With 80% of projects failing to deliver value, learn how to close the gap between ambition and execution - and turn potential into patient impact.